SCHEMBL27360401

SCHEMBL27360401

O=C(Cl)c1ccn(-c2ccccc2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.53
MAPT P10636 2/20 0.50
TSHR P16473 1/20 0.50
HTT P42858 1/20 0.50
HSD17B10 Q99714 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.46
ELOVL1 Q9BW60 5/20 0.45
KDM4E B2RXH2 2/20 0.43
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KCNH2 Q12809 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
USP30 Q70CQ3 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27790040 0.85 CYP2C9 (0.56) CYP2C9MAPTTSHRHTTHSD17B10
SCHEMBL1063920 0.85 CYP2C9 (0.61) CYP2C9MAPTTSHRHTTHSD17B10
SCHEMBL31587160 0.84 ALDH1A1 (0.50) CYP2C9MAPTL3MBTL1LMNAGAA
SCHEMBL4473648 0.81 MAPT (0.58) CYP2C9MAPTTSHRHTTHSD17B10
SCHEMBL725497 0.81 CYP2C9 (0.53) CYP2C9MAPTTSHRHTTHSD17B10
SCHEMBL18997594 0.77 ELOVL1 (0.50) CYP2C9MAPTTSHRHTTHSD17B10
SCHEMBL15401858 0.77 MAPT (0.54) CYP2C9MAPTTSHRHTTHSD17B10
SCHEMBL1062877 0.77 ELOVL1 (0.50) CYP2C9MAPTTSHRHTTHSD17B10
SCHEMBL17321495 0.77 ELOVL1 (0.50) CYP2C9MAPTTSHRHTTHSD17B10
SCHEMBL28662399 0.77 CYP2C9 (0.76) CYP2C9MAPTTSHRHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1072210-C 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors SANOFI SYNTHELABO (FR) 2001-10-03 CN disclosed